Navigation Links
Pain-killer Drug Can Help Fight Breast Cancer

A new study using tissue cultures suggests, that a pain killing medication helps by halting the production of an enzyme that is key to a common form of breast cancer. The name of the painkiller is Nimesulide. //

In the labs experiments on breast cancer cells, scientists found that derivatives of nimesulide stopped the production of aromatase, the enzyme implicated in estrogen-dependent breast cancer. This form of cancer is the most common breast cancer in postmenopausal women. Aromatase converts hormones called androgens into estrogens, Estrogen is a powerful mitogen, which is an agent that causes cells to divide, and too much estrogen can cause cells to divide too quickly.

Robert Brueggemeier, professor of medicinal chemistry and pharmacognosy and dean of the College of Pharmacy at Ohio State University, and the co-author of the study states that many women with estrogen-dependent breast cancer take aromatase inhibitors to control their disease, the problem is that the current inhibitor drugs halt estrogen production throughout the body. Meaning that other parts like bones and brains, which need normal aromatase production, might suffer.

The results suggest that nimesulide may block aromatase production only in breast tissue. Nimesulide is a non-steroidal anti-inflammatory drug (NSAID), used for pain and inflammation. Studies of other NSAIDs, such as ibuprofen, have suggested that NSAIDs may reduce breast cancer incidence by 40 percent. They said that by altering certain basic chemical structure of the drug, they could create several variations or analogs, of nimesulide. Nimesulide was banned from clinical and over the counter use in the United States due to rare cases of liver damage and related deaths.

The researchers took several of these analogs and in laboratory cultures, tested their effects on estrogen-dependent breast cancer cells taken from human breast tissue. They also tested them on human placental cells to see if the analogs would stop aromatase production in these cells. They found that the analogs stopped aromatase production in the breast cells, but not in the placental cells.

Brueggemeierm, stated that aromatase is important for normal functions of many tissues in the body, they still had to test it on other tissues. He further stated that the next step would be to see and study how the analogs affect other types of tissues to make sure that nimesulides aromatase-inhibiting effects are truly isolated to breast tissue. And then to learn how effective these compounds are when they are actually inside the body and what the potential side effects may be.


'"/>




Related medicine news :

1. Fight Heart disease and Pain with Meditation
2. Fight anemia by fortifying crops with iron!!!!!!!!
3. Fight arthritic pain with acupuncture
4. Smallpox Vaccine May Help Fight Cervical Cancer
5. Fight against E.coli
6. Red Wine Helps Fight Heart disease
7. Fish Oil Fights Arrhythmias, Sudden Death
8. SARS-Free Taiwan to Mark End Phase of Global Fight
9. Few Parents Help Kids Fight Acne
10. Common Cold Found to Fight Cancer
11. The Possibility Of Fighting HIV with Another Virus Questioned
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/22/2017)... ... September 22, 2017 , ... Global ... diseases through research, education and awareness, today announced the appointment of Timothy J. ... microbiologist, Dr. Sellati has more than 20 years of research experience with Lyme ...
(Date:9/21/2017)... ... September 21, 2017 , ... SABRE is raising awareness about personal ... to the end of November. , The Chicago, Illinois, based self-defense brand has been ... them about the ease of taking their personal safety into their own hands. , ...
(Date:9/21/2017)... Virginia (PRWEB) , ... September 21, 2017 , ... ... health in their communities, nine governmental public health departments have been awarded five-year ... accreditation decisions mean that the benefits of being served by a PHAB-accredited ...
(Date:9/21/2017)... ... September 21, 2017 , ... The New England Center for Children® ... the election of Yie-Hsin Hung to the Board of Directors. , “The New ... Directors. Ms. Hung is an invaluable addition to our team,” said Vincent Strully, Jr., ...
(Date:9/21/2017)... ... ... FlipBelt, the fitness brand that specializes in problem solving fitness accessories, has ... the launch of their FlipBelt Crops. , The new fitness bottoms feature an integrated ... at the gym, on the trail, or on-the-go. , “We always thought the FlipBelt ...
Breaking Medicine News(10 mins):
(Date:9/9/2017)... Sept. 8, 2017 Dealmed Medical Supplies, ... of medical equipment, supplies, drugs, vaccines, and specialty medical ... into an agreement to acquire Vantage Medical Supplies, a ... Holtsville, New York . ... new and emerging medical practices, will operate under the ...
(Date:9/7/2017)... Sept. 7, 2017  Eli Lilly and Company ... to streamline operations to more efficiently focus resources ... cost structure. Global workforce reductions, including those from ... to impact approximately 3,500 positions. ... annualized savings of approximately $500 million that will ...
(Date:9/7/2017)... , Sept. 7, 2017 Caris ... focused on fulfilling the promise of precision medicine, ... validate the benefits of its molecular profiling approach ... utilized comprehensive genomic profiling plus (CGP+) with Caris ... patient,s tumor on a molecular level, leading to ...
Breaking Medicine Technology: